切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Flk1 - Angiotensin AT2 Receptors - P-glycoprotein (P-gp)

10 件产品

每页
清除全部
  1. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    中文名: 米哚妥林
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC抑制剂
      ≥57.1 mg/mL
      insoluble in H2O
  2. PD123319
    B2206 PD123319
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体的拮抗剂
      ≥22.4 mg/mL
      ≥104.2 mg/mL
  3. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL
  4. Brivanib (BMS-540215)
    A2597 Brivanib (BMS-540215)
    中文名: 布立尼布
    Target: VEGFR|FGFR|Flk1
    Summary: VEGFR-2的ATP竞争性抑制剂
      ≥18.5 mg/mL
      insoluble in H2O
  5. Zosuquidar
    A3956 Zosuquidar
    Target: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)
    Summary: MDR调节剂
      Soluble in DMSO
  6. Tariquidar methanesulfonate, hydrate
    A3859 Tariquidar methanesulfonate, hydrate
    中文名: 他立喹达二甲磺酸盐六水合物
    Target: P-glycoprotein (P-gp)
    Summary: P-糖蛋白抑制剂
      ≥56.2 mg/mL
      insoluble in H2O
  7. PD 123319 ditrifluoroacetate
    A3704 PD 123319 ditrifluoroacetate
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体拮抗剂
      ≥110.2 mg/mL
      ≥73.7 mg/mL
  8. Elacridar
    A3384 Elacridar
    中文名: 依克立达
    Target: P-glycoprotein (P-gp)
    Summary: BCRP抑制剂
      ≥56.4 mg/mL
      insoluble in H2O
  9. Tariquidar
    A8208 Tariquidar
     2 Citation
    中文名: 他立喹达
    Target: P-glycoprotein (P-gp)
    Summary: P-糖蛋白抑制剂
      ≥16.17 mg/mL
      insoluble in H2O
  10. GDC-0449 (Vismodegib)
    A3021 GDC-0449 (Vismodegib)
     1 Citation
    中文名: 维莫德吉
    Target: P-glycoprotein (P-gp)|Hedgehog
    Summary: Hedgehog拮抗剂
      ≥21.08 mg/mL
      insoluble in H2O

10 件产品

每页